Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The landscape of postsurgical recurrence patterns in diffuse low-grade gliomas.

Ferracci FX, Michaud K, Duffau H.

Crit Rev Oncol Hematol. 2019 Jun;138:148-155. doi: 10.1016/j.critrevonc.2019.04.009. Epub 2019 Apr 15. Review.

PMID:
31092371
2.

Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up.

Duffau H.

Acta Neurochir (Wien). 2016 Jan;158(1):51-8. doi: 10.1007/s00701-015-2621-3. Epub 2015 Nov 3.

PMID:
26530708
3.

Delayed leptomeningeal and subependymal seeding after multiple surgeries for supratentorial diffuse low-grade gliomas in adults.

Alvarez de Eulate-Beramendi S, Rigau V, Taillandier L, Duffau H.

J Neurosurg. 2014 Apr;120(4):833-9. doi: 10.3171/2013.10.JNS131512. Epub 2013 Nov 29.

PMID:
24286144
4.

A new philosophy in surgery for diffuse low-grade glioma (DLGG): oncological and functional outcomes.

Duffau H.

Neurochirurgie. 2013 Feb;59(1):2-8. doi: 10.1016/j.neuchi.2012.11.001. Epub 2013 Feb 12. Review.

5.

The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Ryken TC, Parney I, Buatti J, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):551-83. doi: 10.1007/s11060-015-1948-1. Epub 2015 Nov 3. Review.

PMID:
26530266
6.

Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Nahed BV, Redjal N, Brat DJ, Chi AS, Oh K, Batchelor TT, Ryken TC, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):609-30. doi: 10.1007/s11060-015-1910-2. Epub 2015 Nov 3. Review.

PMID:
26530264
7.

Free survival time of recurrence and malignant transformation and associated factors in patients with supratentorial low-grade gliomas.

Sakarunchai I, Sangthong R, Phuenpathom N, Phukaoloun M.

J Med Assoc Thai. 2013 Dec;96(12):1542-9.

PMID:
24511718
8.

Higher-Order Surgical Questions for Diffuse Low-Grade Gliomas: Supramaximal Resection, Neuroplasticity, and Screening.

Duffau H.

Neurosurg Clin N Am. 2019 Jan;30(1):119-128. doi: 10.1016/j.nec.2018.08.009. Epub 2018 Nov 1. Review.

PMID:
30470399
9.

Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.

Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A.

J Neurosurg. 2010 Jan;112(1):10-7. doi: 10.3171/2008.10.JNS08608.

PMID:
19361270
10.

Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups.

Chun SJ, Park SH, Park CK, Kim JW, Kim TM, Choi SH, Lee ST, Kim IH.

Radiother Oncol. 2018 Aug;128(2):254-259. doi: 10.1016/j.radonc.2018.05.024. Epub 2018 Jun 21.

PMID:
29937212
11.

Chemotherapy for diffuse low-grade gliomas in adults.

Ducray F.

Rev Neurol (Paris). 2011 Oct;167(10):673-9. doi: 10.1016/j.neurol.2011.08.006. Epub 2011 Sep 8. Review.

PMID:
21906770
12.

Identifying clinical risk in low grade gliomas and appropriate treatment strategies, with special emphasis on the role of surgery.

Boissonneau S, Duffau H.

Expert Rev Anticancer Ther. 2017 Aug;17(8):703-716. doi: 10.1080/14737140.2017.1342537. Epub 2017 Jun 28. Review.

PMID:
28608763
13.

Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.

Pallud J, Blonski M, Mandonnet E, Audureau E, Fontaine D, Sanai N, Bauchet L, Peruzzi P, Frénay M, Colin P, Guillevin R, Bernier V, Baron MH, Guyotat J, Duffau H, Taillandier L, Capelle L.

Neuro Oncol. 2013 May;15(5):595-606. doi: 10.1093/neuonc/nos331. Epub 2013 Feb 7.

14.

Diffuse low-grade glioma, oncological outcome and quality of life: a surgical perspective.

Duffau H.

Curr Opin Oncol. 2018 Nov;30(6):383-389. doi: 10.1097/CCO.0000000000000483. Review.

PMID:
30124519
15.

The etiopathogenesis of diffuse low-grade gliomas.

Darlix A, Gozé C, Rigau V, Bauchet L, Taillandier L, Duffau H.

Crit Rev Oncol Hematol. 2017 Jan;109:51-62. doi: 10.1016/j.critrevonc.2016.11.014. Epub 2016 Nov 27. Review.

PMID:
28010898
16.

[Update on surgery for diffuse low-grade gliomas: brain mapping, hodotopy and neuroplasticity].

Duffau H.

Bull Acad Natl Med. 2011 Jan;195(1):37-49; discussion 49-51. French.

PMID:
22039702
17.

A nonradiated grade II glioma that underwent delayed malignant transformation to a gliosarcoma with meningeal growth and dissemination.

Rech F, Rigau V, Fabbro M, Kerr C, Gauchotte G, Taillandier L, Duffau H.

J Neurol Surg A Cent Eur Neurosurg. 2014 Nov;75(6):485-90. doi: 10.1055/s-0034-1372437. Epub 2014 Jun 27.

PMID:
24971682
18.

Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.

Gömöri E, Pál J, Kovács B, Dóczi T.

Diagn Pathol. 2012 Jan 20;7:8. doi: 10.1186/1746-1596-7-8.

19.

[Malignant gliomas--radiotherapy].

Schratter-Sehn A.

Wien Med Wochenschr. 2006 Jun;156(11-12):342-5. German.

PMID:
16944365
20.

Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.

Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M.

J Neurosurg. 1995 Apr;82(4):536-47.

PMID:
7897512

Supplemental Content

Support Center